Sounds like Takeda is still hoping to not have to wait for the outcomes trial. If they do, then any possible approval is likely three or four years out.
Furiex has an interesting IB-d drug - not sure what else they have.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.